Concepedia

S. Michael Rothenberg

SM

42

Publications

7.5K

Citations

30

H-Index

2001

Active since

Affiliations

Massachusetts General Hospital(Current)

Loxo Oncology at Lilly (United States)

Harvard University

Memorial Sloan Kettering Cancer Center

Dana-Farber Cancer Institute

S. Michael Rothenberg is an author at Massachusetts General Hospital specializing in medicine, oncology, and cancer research.

ORCID

Top concepts

Publications per year

2001–2024

42

Publications

42

Isolation of circulating tumor cells using a microvortex-generating herringbone-chip

Shannon L. Stott, Chia‐Hsien Hsu, Dina Tsukrov et al. · Proceedings of the National Academy of Sciences · 2010 · 1.6K citations · Full text

Efficacy of Selpercatinib in <i>RET</i> Fusion–Positive Non–Small-Cell Lung Cancer

Alexander Drilon, Geoffrey R. Oxnard, Daniel Shao-Weng Tan et al. · New England Journal of Medicine · 2020 · 810 citations · Full text

Efficacy of Selpercatinib in <i>RET</i> -Altered Thyroid Cancers

Lori J. Wirth, Eric J. Sherman, Bruce Robinson et al. · New England Journal of Medicine · 2020 · 731 citations · Full text

EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy

Joachim Lupberger, Mirjam B. Zeisel, Fei Xiao et al. · Nature Medicine · 2011 · 684 citations · Full text

, , +6

Selective RET kinase inhibition for patients with RET-altered cancers

Vivek Subbiah, Vamsidhar Velcheti, Brian B. Tuch et al. · Annals of Oncology · 2018 · 422 citations · Full text

Rows per page

1–5 of 42